Shares of Lam Research Corp. LRCX advanced 1.09% to $71.67 Wednesday, on what proved to be an all-around great trading ...

Stifel Financial Corp dialed up its commitment to Lam Research in a move so bold it might’ve short-circuited calculators.

NEW YORK (Reuters) -Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the ...

Lam Research Corporation LRCX recently posted strong third-quarter fiscal 2025 results, helping its shares rise 7% since the ...

Frequent visitors to The Huntington will be surprised to see starkly different signage as they enter the gates. The ...

She visited Fann hospital in Dakar, where neurologist Dr. Pedro Rodriguez measured her lung capacity. He suspects Mariama had ...

As the opioid crisis continues, the number of babies born with neonatal opioid withdrawal syndrome (NOWS) – a condition that affects infants whose mothers used opioids during pregnancy – has risen ...

Morgan Stanley analyst Joseph Moore maintained a Hold rating on Lam Research (LRCX – Research Report) today and set a price target of $82.00.

Deutsche Bank analyst Melissa Weathers lowered the firm’s price target on Lam Research (LRCX) to $70 from $78 and keeps a Hold rating on the ...